Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Sokol

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Pediatric Blood & Cancer|September 15, 2025
Large-Bore Vacuum Suction Biopsy of Pediatric Soft Tissue Tumors: A 5-Year Retrospective Analysis of Safety and EffectivenessAbhinav R Balu, Shankar Rajeswaran, Nitin R Wadhwani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2020
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG ProjectElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Reply to K. Beiske et alElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Research Square|June 17, 2024
Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathologyMark Applebaum, Siddhi Ramesh, Emma Dyer, et al.
Pediatric Blood & Cancer|September 12, 2025
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid TumorsMatthew E Campbell, Sonja Stutzman, Sharon Primeaux, et al.
Pediatric Blood & Cancer|March 13, 2026
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective StudyBenjamin J Lerman, Madeleine King, Rajen Mody, et al.
Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2024
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyRochelle Bagatell, Julie R Park, Sahaja Acharya, et al.
Transplantation and Cellular Therapy|November 14, 2025
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter StudyZahra Hudda, Aaron Webster, Eric Anderson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pediatric Blood & Cancer|September 15, 2025
Large-Bore Vacuum Suction Biopsy of Pediatric Soft Tissue Tumors: A 5-Year Retrospective Analysis of Safety and EffectivenessAbhinav R Balu, Shankar Rajeswaran, Nitin R Wadhwani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2020
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG ProjectElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Reply to K. Beiske et alElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Research Square|June 17, 2024
Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathologyMark Applebaum, Siddhi Ramesh, Emma Dyer, et al.
Pediatric Blood & Cancer|September 12, 2025
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid TumorsMatthew E Campbell, Sonja Stutzman, Sharon Primeaux, et al.
Pediatric Blood & Cancer|March 13, 2026
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective StudyBenjamin J Lerman, Madeleine King, Rajen Mody, et al.
Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2024
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyRochelle Bagatell, Julie R Park, Sahaja Acharya, et al.
Transplantation and Cellular Therapy|November 14, 2025
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter StudyZahra Hudda, Aaron Webster, Eric Anderson, et al.
Pageof 2